Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have been assigned an average recommendation of “Hold” from the sixteen ratings firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, thirteen have given a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $14.77.
AVTR has been the topic of a number of recent research reports. Stifel Nicolaus raised their target price on shares of Avantor from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Thursday, October 29th. Robert W. Baird lifted their target price on Avantor from $17.00 to $18.00 and gave the company an “outperform” rating in a research note on Thursday, October 29th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $17.00 target price on shares of Avantor in a report on Thursday, October 29th. Jefferies Financial Group upgraded Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price target on the stock in a research report on Wednesday, July 29th. Finally, Morgan Stanley raised their price target on Avantor from $14.00 to $15.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 13th.
Get Our Latest Research Report on Avantor
Avantor Stock Up 2.3%
Shares of NYSE:AVTR opened at $15.49 on Friday. The company’s fifty day moving average is $15.60 and its two-hundred day moving average is $11.32. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.89. Avantor has a 1-year low of $7.26 and a 1-year high of $17.45. The stock has a market capitalization of $10.50 billion, a price-to-earnings ratio of 30.98, a price-to-earnings-growth ratio of 7.00 and a beta of 0.95.
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings results on Wednesday, October 28th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.21 by $0.01. Avantor had a net margin of 5.08% and a return on equity of 9.79%. The business had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business posted $0.22 EPS. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Equities analysts anticipate that Avantor will post 0.82 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. grew its position in shares of Avantor by 11.5% during the third quarter. Russell Investments Group Ltd. now owns 1,141,476 shares of the company’s stock worth $17,182,000 after acquiring an additional 117,633 shares during the last quarter. Fifth Third Bancorp increased its holdings in shares of Avantor by 60.6% in the 3rd quarter. Fifth Third Bancorp now owns 906,058 shares of the company’s stock worth $13,636,000 after acquiring an additional 341,926 shares during the period. Maryland State Retirement & Pension System increased its holdings in shares of Avantor by 28.2% in the 3rd quarter. Maryland State Retirement & Pension System now owns 40,636 shares of the company’s stock worth $612,000 after acquiring an additional 8,935 shares during the period. Ritholtz Wealth Management increased its holdings in shares of Avantor by 111.7% in the 3rd quarter. Ritholtz Wealth Management now owns 24,794 shares of the company’s stock worth $373,000 after acquiring an additional 13,081 shares during the period. Finally, Machina Capital S.A.S. bought a new stake in Avantor in the 3rd quarter valued at about $252,000. 95.08% of the stock is currently owned by institutional investors.
About Avantor
Avantor, Inc is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers.
The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.
Avantor traces its history to J.T.
Read More
- Five stocks we like better than Avantor
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
